TRIQUIGNEAUX Maximilien – Trademark Portfolio
Entity Type: 01
TRIQUIGNEAUX Maximilien holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 14 (Jewelry) — 6 filings in this category. The portfolio also extends into Class 18 (Leather Goods) across 5 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include DOUGLAS, SKINDIVER, and NSA NOVAVIT.
15 allée de l?Escaladiero
F-13500 Martigues
Showing of trademarks Trademarks
Trademark Classifications
TRIQUIGNEAUX Maximilien's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Precious metals and their alloys; jewellery, precious stones; horological instruments
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does TRIQUIGNEAUX Maximilien have?
TRIQUIGNEAUX Maximilien has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 3 abandoned.
What trademark classes does TRIQUIGNEAUX Maximilien file in?
TRIQUIGNEAUX Maximilien files trademarks across 5 Nice Classification classes. The most active classes are Class 14 (Jewelry), Class 18 (Leather Goods), Class 25 (Clothing), Class 8 (Hand Tools), Class 28 (Toys & Sporting Goods). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.
What are TRIQUIGNEAUX Maximilien's most well-known trademarks?
TRIQUIGNEAUX Maximilien's registered trademark portfolio includes well-known marks such as DOUGLAS, SKINDIVER, and NSA NOVAVIT. These are among 3 currently registered trademarks in the portfolio.
What is TRIQUIGNEAUX Maximilien's trademark registration success rate?
TRIQUIGNEAUX Maximilien has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.